The following winners were selected among 30 contenders within 5 categorieswho demonstrated new offerings on the show floor. Products were judged byconference attendees through a balloting process.

--  IT/Informatics:    Ingenuity Systems - Path Designer    Ingenuity Systems introduces Path Designer Analysis 6, the publishing    tool within IPA 6 that transforms networks and pathways into    publication-quality graphics rich with color, customized text,    biological icons, and organelles. Path Designer's interactive images    link directly to Ingenuity's knowledge base. This easy-to-use graphics    package completes the research workflow -- from data analysis to    publication of results -- within a single software solution.    www.ingenuity.com--  Instrumentation:    Fluidigm Corporation - BioMark™ Real Time PCR System    BioMark(TM) Real Time PCR System -- Bridging the gap between discovery    and clinically useful biomarkers requires next-generation technology --    tools that deliver radical new efficiency for the analysis of nucleic    acids. The BioMark(TM) Real Time PCR System meets this challenge    through integrated fluidic circuits (IFCs), which represent a    fundamental advance in simplicity and throughput over microwell plates.    www.fluidigm.com--  Drug Discovery Tools:    There was a tie    Enamine LLC - Pharmacological Diversity Set    Enamine introduces their new Pharmacological Diversity Set (PDS) which    is a unique alternative to common Structural Diversity Sets (SDS).    While SDS was designed to offer maximum diversity based on chemical    structures alone, PDS has been designed to offer clustered diversity    sets with biological activity in mind. This unique set was designed by    evaluating over 3000 pharmacological activities from the literature for    each compound in our Drug-Like Collection. www.enamine.net    Thermo Scientific/Dharmacon Products - Accell(TM) siRNA Reagents &    SMARTvector shRNA Lentiviral    Accell(TM) siRNA Reagents delivers knockdown in every cell type tested    to date, including primary, neuronal, and stem cells, without a    transfection reagent or viral vector. Accell siRNA has a 2-step    protocol that requires no optimization, yet provides highly specific    silencing without non-specific delivery effects that cause toxicity and    false phenotypes. www.thermo.com/dharmacon    SMARTvector shRNA Lentiviral platform merges multiple design    innovations that improve silencing functionality and specificity,    including a novel microRNA-based expression system and specialized    selection algorithm. Delivered by high-titer lentiviral particles,    functional long-term knockdown can be achieved in a broad range of cell    types. www.thermo.com/dharmacon--  Molecular Diagnostics    Decision Biomarkers Inc. - MAX BIOCHIP™    Decision Biomarkers launches AVANTRA(TM) biomarker workstation along    with its innovative MAX BIOCHIP(TM) 8-plex cytokine immunoassay. The    system's ease-of-use enables users to generate data in real-time by    virtually anyone, anywhere in drug development and clinical trials    accelerating decision making and improving project productivity.    www.decisionbiomarkers.com--  Cells and Assays    Stem Cell Technologies, Inc. - mTeSR™1    mTeSR(TM)1 is a novel, defined medium designed to maintain human    embryonic and induced pluripotent stem cells in the undifferentiated    state without the use of feeders. This product provides consistent    culture conditions for pluripotent stem cells and considerably    simplifies the process of maintaining these clinically important cells    undifferentiated. www.stemcell.com    

About the Molecular Medicine Tri-Conference

The Molecular Medicine Tri-Conference is the largest annual West Coastbiotech conference, and brings together over 2,800 pharmaceutical andbiotech leaders from over 40 countries. This year's event featured over 200presentations, 150 exhibit booths, 75 scientific posters, 3 plenarykeynotes, and scientific short courses including the expanded BiotechPharma Partnership. For more information, please visitwww.Tri-Conference.com.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (CHI) is the preeminent life science networkfor leading researchers and business experts from top pharmaceutical,biotech and academic organizations. CHI's portfolio of products includesCambridge Healthtech Institute Conferences, Insight Pharma Reports,Cambridge Marketing Consultants, Cambridge Meeting Planners and CambridgeHealthtech's Media Group, which includes numerous e-newsletters as well asBio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop qualityinformation sources that provide valuable new insights and competing pointsof view while offering balanced coverage of the latest developments. Basicresearch related to commercial implications is covered, with heavy emphasisplaced on end-user insights into new products and technology as well ascoverage on the strategy behind the business.